Nonpartisan civic infrastructure
AllCiv·Legis1
·

S. 4535

BillFederalSenateIntroduced
To amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs, medical devices, generic drugs, and biosimilar biological products, and for other purposes.
About This Bill
Introduced
Introduced
July 14, 2022
Cosponsors (0)
None
View PDF ↗
SummaryFull TextCommentsAnnotations

Annotations on Text

0 annotations · Highlight text on the Summary or Full Text tab to add one
No annotations yet. Highlight a passage of the text to add one.

Take Action

Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.